Clinical Trial Update: Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pentosan polysulfate sodium and meclofenamic acid for psychotic disorders, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Meclofenamic acid (Meclofenamic acid)
• Pentosan polysulfate sodium (Pentosan polysulfate sodium)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Psychotic Disorders, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26